Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-12-018085
Filing Date
2012-05-24
Accepted
2012-05-24 17:21:31
Documents
1
Period of Report
2012-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3767
  Complete submission text file 0001127602-12-018085.txt   5090
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
Jensen Peder (Reporting) CIK: 0001518724 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 12868543